Skip to main content

Table 1 Anthropometric measures of participants during HPL and LPL krill and control oil interventions

From: Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil

Parameter Treatment Baseline Endpoint Change (Difference)
Body Weight (Kg) HPL Krill oil 67.53 ± 2.75 67.96 ± 2.63 0.43 ± 0.37
LPL krill oil 67.99 ± 2.77 67.74 ± 2.73 −0.25 ± 0.22a
Control 67.56 ± 2.46 67.73 ± 2.44 0.18 ± 0.22
BMI (kg/m2) HPL Krill oil 23.62 ± 0.68 23.75 ± 0.63 0.13 ± 0.15
LPL krill oil 23.79 ± 0.71 23.69 ± 0.71 −0.10 ± 0.08
Control 23.61 ± 0.63 23.67 ± 0.62 0.06 ± 0.09
Waist (cm) HPL Krill oil 77.95 ± 1.98 78.20 ± 1.93 0.25 ± 0.27
LPL krill oil 78.25 ± 2.03 77.81 ± 2.05 −0.43 ± 0.37
Control 78.05 ± 1.80 78.14 ± 1.78 0.09 ± 0.15
Hip (cm) HPL Krill oil 92.04 ± 1.19 92.45 ± 1.14 0.41 ± 0.34
LPL krill oil 92.69 ± 1.22 92.92 ± 1.20 0.23 ± 0.28
Control 92.70 ± 1.10 92.71 ± 1.07 0.01 ± 0.12
Waist/Hip ratio HPL Krill oil 0.85 ± 0.02 0.84 ± 0.02 0.00 ± 0.00
LPL krill oil 0.84 ± 0.02 0.84 ± 0.02 −0.01 ± 0.00
Control 0.84 ± 0.02 0.84 ± 0.01 0.00 ± 0.00
Systolic BP (mmHg) HPL Krill oil 106.80 ± 2.63 108.14 ± 2.00a 1.35 ± 1.39
LPL krill oil 106.35 ± 2.45 103.97 ± 2.73 −2.38 ± 1.56
Control 107.99 ± 2.13 105.89 ± 2.36 −2.11 ± 1.15
Diastolic BP (mmHg) HPL Krill oil 71.45 ± 1.69 72.53 ± 1.32 1.09 ± 0.88
LPL krill oil 71.17 ± 1.96 70.5 ± 1.86 −0.67 ± 1.34
Control 72.26 ± 1.68 71.05 ± 1.84 −1.21 ± 1.05
Heart rate (Beats/min) HPL Krill oil 71.35 ± 2.43 70.25 ± 1.72 −1.10 ± 2.07
LPL krill oil 73.25 ± 2.23 69.1 ± 1.74 −4.15 ± 1.70
Control 71.55 ± 1.66 71.80 ± 1.65 0.25 ± 1.09
  1. Values are expressed as Mean ± SEM. n = 20. adenotes significance compared with LPL krill oil intervention